Click for best price

Longacting Shortacting Oral Contraceptives Market Size, Share 2025

Report Overview

Oral contraceptives (birth control pills) are hormone-containing medications that are taken by mouth to prevent pregnancy. They prevent pregnancy by inhibiting ovulation and also by preventing sperm from penetrating through the cervix.

The global Long-acting and Short-acting Oral Contraceptives market size was estimated at USD 611 million in 2023 and is projected to reach USD 818.36 million by 2032, exhibiting a CAGR of 3.30% during the forecast period.

North America Long-acting and Short-acting Oral Contraceptives market size was estimated at USD 168.34 million in 2023, at a CAGR of 2.83% during the forecast period of 2024 through 2032.

This report provides a deep insight into the global Long-acting and Short-acting Oral Contraceptives market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Long-acting and Short-acting Oral Contraceptives Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Long-acting and Short-acting Oral Contraceptives market in any manner.

Global Long-acting and Short-acting Oral Contraceptives Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Bayer

Paladin Labs

Theramex (Teva)

Pfizer

Apotex

HRA Pharma

HLL Life Care

Mankind

Piramal

Allergan

Market Segmentation (by Type)

Combined Contraceptive Pill

Low Dose Oral Contraceptive

Market Segmentation (by Application)

Hospital Pharmacies

Private Clinics

Retail Pharmacies

E-Commerce

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Long-acting and Short-acting Oral Contraceptives Market

Overview of the regional outlook of the Long-acting and Short-acting Oral Contraceptives Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Long-acting and Short-acting Oral Contraceptives Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Long-acting and Short-acting Oral Contraceptives, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.

Chapter 13 is the main points and conclusions of the report.

Report Attributes	Report Details
Report Title	Long-acting and Short-acting Oral Contraceptives Market, Global Outlook and Forecast 2025-2030
Historical Year	2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year	2024
Forecast Year	2032
Number of Pages	NA Pages
Customization Available	Yes, the report can be customized as per your need.

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Long-acting and Short-acting Oral Contraceptives
1.2 Key Market Segments
1.2.1 Long-acting and Short-acting Oral Contraceptives Segment by Type
1.2.2 Long-acting and Short-acting Oral Contraceptives Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Long-acting and Short-acting Oral Contraceptives Market Overview
2.1 Global Market Overview
2.1.1 Global Long-acting and Short-acting Oral Contraceptives Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Long-acting and Short-acting Oral Contraceptives Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Long-acting and Short-acting Oral Contraceptives Market Competitive Landscape
3.1 Global Long-acting and Short-acting Oral Contraceptives Sales by Manufacturers (2019-2024)
3.2 Global Long-acting and Short-acting Oral Contraceptives Revenue Market Share by Manufacturers (2019-2024)
3.3 Long-acting and Short-acting Oral Contraceptives Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Long-acting and Short-acting Oral Contraceptives Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Long-acting and Short-acting Oral Contraceptives Sales Sites, Area Served, Product Type
3.6 Long-acting and Short-acting Oral Contraceptives Market Competitive Situation and Trends
3.6.1 Long-acting and Short-acting Oral Contraceptives Market Concentration Rate
3.6.2 Global 5 and 10 Largest Long-acting and Short-acting Oral Contraceptives Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Long-acting and Short-acting Oral Contraceptives Industry Chain Analysis
4.1 Long-acting and Short-acting Oral Contraceptives Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Long-acting and Short-acting Oral Contraceptives Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Long-acting and Short-acting Oral Contraceptives Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Long-acting and Short-acting Oral Contraceptives Sales Market Share by Type (2019-2024)
6.3 Global Long-acting and Short-acting Oral Contraceptives Market Size Market Share by Type (2019-2024)
6.4 Global Long-acting and Short-acting Oral Contraceptives Price by Type (2019-2024)
7 Long-acting and Short-acting Oral Contraceptives Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Long-acting and Short-acting Oral Contraceptives Market Sales by Application (2019-2024)
7.3 Global Long-acting and Short-acting Oral Contraceptives Market Size (M USD) by Application (2019-2024)
7.4 Global Long-acting and Short-acting Oral Contraceptives Sales Growth Rate by Application (2019-2024)
8 Long-acting and Short-acting Oral Contraceptives Market Consumption by Region
8.1 Global Long-acting and Short-acting Oral Contraceptives Sales by Region
8.1.1 Global Long-acting and Short-acting Oral Contraceptives Sales by Region
8.1.2 Global Long-acting and Short-acting Oral Contraceptives Sales Market Share by Region
8.2 North America
8.2.1 North America Long-acting and Short-acting Oral Contraceptives Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Long-acting and Short-acting Oral Contraceptives Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Long-acting and Short-acting Oral Contraceptives Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Long-acting and Short-acting Oral Contraceptives Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Long-acting and Short-acting Oral Contraceptives Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Long-acting and Short-acting Oral Contraceptives Market Production by Region
9.1 Global Production of Long-acting and Short-acting Oral Contraceptives by Region (2019-2024)
9.2 Global Long-acting and Short-acting Oral Contraceptives Revenue Market Share by Region (2019-2024)
9.3 Global Long-acting and Short-acting Oral Contraceptives Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Long-acting and Short-acting Oral Contraceptives Production
9.4.1 North America Long-acting and Short-acting Oral Contraceptives Production Growth Rate (2019-2024)
9.4.2 North America Long-acting and Short-acting Oral Contraceptives Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Long-acting and Short-acting Oral Contraceptives Production
9.5.1 Europe Long-acting and Short-acting Oral Contraceptives Production Growth Rate (2019-2024)
9.5.2 Europe Long-acting and Short-acting Oral Contraceptives Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Long-acting and Short-acting Oral Contraceptives Production (2019-2024)
9.6.1 Japan Long-acting and Short-acting Oral Contraceptives Production Growth Rate (2019-2024)
9.6.2 Japan Long-acting and Short-acting Oral Contraceptives Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Long-acting and Short-acting Oral Contraceptives Production (2019-2024)
9.7.1 China Long-acting and Short-acting Oral Contraceptives Production Growth Rate (2019-2024)
9.7.2 China Long-acting and Short-acting Oral Contraceptives Production, Revenue, Price and Gross Margin (2019-2024)
10 Key Companies Profile
10.1 Bayer
10.1.1 Bayer Long-acting and Short-acting Oral Contraceptives Basic Information
10.1.2 Bayer Long-acting and Short-acting Oral Contraceptives Product Overview
10.1.3 Bayer Long-acting and Short-acting Oral Contraceptives Product Market Performance
10.1.4 Bayer Business Overview
10.1.5 Bayer Long-acting and Short-acting Oral Contraceptives SWOT Analysis
10.1.6 Bayer Recent Developments
10.2 Paladin Labs
10.2.1 Paladin Labs Long-acting and Short-acting Oral Contraceptives Basic Information
10.2.2 Paladin Labs Long-acting and Short-acting Oral Contraceptives Product Overview
10.2.3 Paladin Labs Long-acting and Short-acting Oral Contraceptives Product Market Performance
10.2.4 Paladin Labs Business Overview
10.2.5 Paladin Labs Long-acting and Short-acting Oral Contraceptives SWOT Analysis
10.2.6 Paladin Labs Recent Developments
10.3 Theramex (Teva)
10.3.1 Theramex (Teva) Long-acting and Short-acting Oral Contraceptives Basic Information
10.3.2 Theramex (Teva) Long-acting and Short-acting Oral Contraceptives Product Overview
10.3.3 Theramex (Teva) Long-acting and Short-acting Oral Contraceptives Product Market Performance
10.3.4 Theramex (Teva) Long-acting and Short-acting Oral Contraceptives SWOT Analysis
10.3.5 Theramex (Teva) Business Overview
10.3.6 Theramex (Teva) Recent Developments
10.4 Pfizer
10.4.1 Pfizer Long-acting and Short-acting Oral Contraceptives Basic Information
10.4.2 Pfizer Long-acting and Short-acting Oral Contraceptives Product Overview
10.4.3 Pfizer Long-acting and Short-acting Oral Contraceptives Product Market Performance
10.4.4 Pfizer Business Overview
10.4.5 Pfizer Recent Developments
10.5 Apotex
10.5.1 Apotex Long-acting and Short-acting Oral Contraceptives Basic Information
10.5.2 Apotex Long-acting and Short-acting Oral Contraceptives Product Overview
10.5.3 Apotex Long-acting and Short-acting Oral Contraceptives Product Market Performance
10.5.4 Apotex Business Overview
10.5.5 Apotex Recent Developments
10.6 HRA Pharma
10.6.1 HRA Pharma Long-acting and Short-acting Oral Contraceptives Basic Information
10.6.2 HRA Pharma Long-acting and Short-acting Oral Contraceptives Product Overview
10.6.3 HRA Pharma Long-acting and Short-acting Oral Contraceptives Product Market Performance
10.6.4 HRA Pharma Business Overview
10.6.5 HRA Pharma Recent Developments
10.7 HLL Life Care
10.7.1 HLL Life Care Long-acting and Short-acting Oral Contraceptives Basic Information
10.7.2 HLL Life Care Long-acting and Short-acting Oral Contraceptives Product Overview
10.7.3 HLL Life Care Long-acting and Short-acting Oral Contraceptives Product Market Performance
10.7.4 HLL Life Care Business Overview
10.7.5 HLL Life Care Recent Developments
10.8 Mankind
10.8.1 Mankind Long-acting and Short-acting Oral Contraceptives Basic Information
10.8.2 Mankind Long-acting and Short-acting Oral Contraceptives Product Overview
10.8.3 Mankind Long-acting and Short-acting Oral Contraceptives Product Market Performance
10.8.4 Mankind Business Overview
10.8.5 Mankind Recent Developments
10.9 Piramal
10.9.1 Piramal Long-acting and Short-acting Oral Contraceptives Basic Information
10.9.2 Piramal Long-acting and Short-acting Oral Contraceptives Product Overview
10.9.3 Piramal Long-acting and Short-acting Oral Contraceptives Product Market Performance
10.9.4 Piramal Business Overview
10.9.5 Piramal Recent Developments
10.10 Allergan
10.10.1 Allergan Long-acting and Short-acting Oral Contraceptives Basic Information
10.10.2 Allergan Long-acting and Short-acting Oral Contraceptives Product Overview
10.10.3 Allergan Long-acting and Short-acting Oral Contraceptives Product Market Performance
10.10.4 Allergan Business Overview
10.10.5 Allergan Recent Developments
11 Long-acting and Short-acting Oral Contraceptives Market Forecast by Region
11.1 Global Long-acting and Short-acting Oral Contraceptives Market Size Forecast
11.2 Global Long-acting and Short-acting Oral Contraceptives Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Long-acting and Short-acting Oral Contraceptives Market Size Forecast by Country
11.2.3 Asia Pacific Long-acting and Short-acting Oral Contraceptives Market Size Forecast by Region
11.2.4 South America Long-acting and Short-acting Oral Contraceptives Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Long-acting and Short-acting Oral Contraceptives by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Long-acting and Short-acting Oral Contraceptives Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Long-acting and Short-acting Oral Contraceptives by Type (2025-2032)
12.1.2 Global Long-acting and Short-acting Oral Contraceptives Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Long-acting and Short-acting Oral Contraceptives by Type (2025-2032)
12.2 Global Long-acting and Short-acting Oral Contraceptives Market Forecast by Application (2025-2032)
12.2.1 Global Long-acting and Short-acting Oral Contraceptives Sales (K MT) Forecast by Application
12.2.2 Global Long-acting and Short-acting Oral Contraceptives Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings

LIST OF TABLES & FIGURES

List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Long-acting and Short-acting Oral Contraceptives Market Size Comparison by Region (M USD)
Table 5. Global Long-acting and Short-acting Oral Contraceptives Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Long-acting and Short-acting Oral Contraceptives Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Long-acting and Short-acting Oral Contraceptives Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting and Short-acting Oral Contraceptives as of 2022)
Table 10. Global Market Long-acting and Short-acting Oral Contraceptives Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Long-acting and Short-acting Oral Contraceptives Sales Sites and Area Served
Table 12. Manufacturers Long-acting and Short-acting Oral Contraceptives Product Type
Table 13. Global Long-acting and Short-acting Oral Contraceptives Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Long-acting and Short-acting Oral Contraceptives
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Long-acting and Short-acting Oral Contraceptives Market Challenges
Table 22. Global Long-acting and Short-acting Oral Contraceptives Sales by Type (K MT)
Table 23. Global Long-acting and Short-acting Oral Contraceptives Market Size by Type (M USD)
Table 24. Global Long-acting and Short-acting Oral Contraceptives Sales (K MT) by Type (2019-2024)
Table 25. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share by Type (2019-2024)
Table 26. Global Long-acting and Short-acting Oral Contraceptives Market Size (M USD) by Type (2019-2024)
Table 27. Global Long-acting and Short-acting Oral Contraceptives Market Size Share by Type (2019-2024)
Table 28. Global Long-acting and Short-acting Oral Contraceptives Price (USD/MT) by Type (2019-2024)
Table 29. Global Long-acting and Short-acting Oral Contraceptives Sales (K MT) by Application
Table 30. Global Long-acting and Short-acting Oral Contraceptives Market Size by Application
Table 31. Global Long-acting and Short-acting Oral Contraceptives Sales by Application (2019-2024) & (K MT)
Table 32. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share by Application (2019-2024)
Table 33. Global Long-acting and Short-acting Oral Contraceptives Sales by Application (2019-2024) & (M USD)
Table 34. Global Long-acting and Short-acting Oral Contraceptives Market Share by Application (2019-2024)
Table 35. Global Long-acting and Short-acting Oral Contraceptives Sales Growth Rate by Application (2019-2024)
Table 36. Global Long-acting and Short-acting Oral Contraceptives Sales by Region (2019-2024) & (K MT)
Table 37. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share by Region (2019-2024)
Table 38. North America Long-acting and Short-acting Oral Contraceptives Sales by Country (2019-2024) & (K MT)
Table 39. Europe Long-acting and Short-acting Oral Contraceptives Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Long-acting and Short-acting Oral Contraceptives Sales by Region (2019-2024) & (K MT)
Table 41. South America Long-acting and Short-acting Oral Contraceptives Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Long-acting and Short-acting Oral Contraceptives Sales by Region (2019-2024) & (K MT)
Table 43. Global Long-acting and Short-acting Oral Contraceptives Production (K MT) by Region (2019-2024)
Table 44. Global Long-acting and Short-acting Oral Contraceptives Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Long-acting and Short-acting Oral Contraceptives Revenue Market Share by Region (2019-2024)
Table 46. Global Long-acting and Short-acting Oral Contraceptives Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Long-acting and Short-acting Oral Contraceptives Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Long-acting and Short-acting Oral Contraceptives Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Long-acting and Short-acting Oral Contraceptives Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Long-acting and Short-acting Oral Contraceptives Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Bayer Long-acting and Short-acting Oral Contraceptives Basic Information
Table 52. Bayer Long-acting and Short-acting Oral Contraceptives Product Overview
Table 53. Bayer Long-acting and Short-acting Oral Contraceptives Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Bayer Business Overview
Table 55. Bayer Long-acting and Short-acting Oral Contraceptives SWOT Analysis
Table 56. Bayer Recent Developments
Table 57. Paladin Labs Long-acting and Short-acting Oral Contraceptives Basic Information
Table 58. Paladin Labs Long-acting and Short-acting Oral Contraceptives Product Overview
Table 59. Paladin Labs Long-acting and Short-acting Oral Contraceptives Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Paladin Labs Business Overview
Table 61. Paladin Labs Long-acting and Short-acting Oral Contraceptives SWOT Analysis
Table 62. Paladin Labs Recent Developments
Table 63. Theramex (Teva) Long-acting and Short-acting Oral Contraceptives Basic Information
Table 64. Theramex (Teva) Long-acting and Short-acting Oral Contraceptives Product Overview
Table 65. Theramex (Teva) Long-acting and Short-acting Oral Contraceptives Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Theramex (Teva) Long-acting and Short-acting Oral Contraceptives SWOT Analysis
Table 67. Theramex (Teva) Business Overview
Table 68. Theramex (Teva) Recent Developments
Table 69. Pfizer Long-acting and Short-acting Oral Contraceptives Basic Information
Table 70. Pfizer Long-acting and Short-acting Oral Contraceptives Product Overview
Table 71. Pfizer Long-acting and Short-acting Oral Contraceptives Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. Pfizer Business Overview
Table 73. Pfizer Recent Developments
Table 74. Apotex Long-acting and Short-acting Oral Contraceptives Basic Information
Table 75. Apotex Long-acting and Short-acting Oral Contraceptives Product Overview
Table 76. Apotex Long-acting and Short-acting Oral Contraceptives Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Apotex Business Overview
Table 78. Apotex Recent Developments
Table 79. HRA Pharma Long-acting and Short-acting Oral Contraceptives Basic Information
Table 80. HRA Pharma Long-acting and Short-acting Oral Contraceptives Product Overview
Table 81. HRA Pharma Long-acting and Short-acting Oral Contraceptives Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. HRA Pharma Business Overview
Table 83. HRA Pharma Recent Developments
Table 84. HLL Life Care Long-acting and Short-acting Oral Contraceptives Basic Information
Table 85. HLL Life Care Long-acting and Short-acting Oral Contraceptives Product Overview
Table 86. HLL Life Care Long-acting and Short-acting Oral Contraceptives Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. HLL Life Care Business Overview
Table 88. HLL Life Care Recent Developments
Table 89. Mankind Long-acting and Short-acting Oral Contraceptives Basic Information
Table 90. Mankind Long-acting and Short-acting Oral Contraceptives Product Overview
Table 91. Mankind Long-acting and Short-acting Oral Contraceptives Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Mankind Business Overview
Table 93. Mankind Recent Developments
Table 94. Piramal Long-acting and Short-acting Oral Contraceptives Basic Information
Table 95. Piramal Long-acting and Short-acting Oral Contraceptives Product Overview
Table 96. Piramal Long-acting and Short-acting Oral Contraceptives Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. Piramal Business Overview
Table 98. Piramal Recent Developments
Table 99. Allergan Long-acting and Short-acting Oral Contraceptives Basic Information
Table 100. Allergan Long-acting and Short-acting Oral Contraceptives Product Overview
Table 101. Allergan Long-acting and Short-acting Oral Contraceptives Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Allergan Business Overview
Table 103. Allergan Recent Developments
Table 104. Global Long-acting and Short-acting Oral Contraceptives Sales Forecast by Region (2025-2032) & (K MT)
Table 105. Global Long-acting and Short-acting Oral Contraceptives Market Size Forecast by Region (2025-2032) & (M USD)
Table 106. North America Long-acting and Short-acting Oral Contraceptives Sales Forecast by Country (2025-2032) & (K MT)
Table 107. North America Long-acting and Short-acting Oral Contraceptives Market Size Forecast by Country (2025-2032) & (M USD)
Table 108. Europe Long-acting and Short-acting Oral Contraceptives Sales Forecast by Country (2025-2032) & (K MT)
Table 109. Europe Long-acting and Short-acting Oral Contraceptives Market Size Forecast by Country (2025-2032) & (M USD)
Table 110. Asia Pacific Long-acting and Short-acting Oral Contraceptives Sales Forecast by Region (2025-2032) & (K MT)
Table 111. Asia Pacific Long-acting and Short-acting Oral Contraceptives Market Size Forecast by Region (2025-2032) & (M USD)
Table 112. South America Long-acting and Short-acting Oral Contraceptives Sales Forecast by Country (2025-2032) & (K MT)
Table 113. South America Long-acting and Short-acting Oral Contraceptives Market Size Forecast by Country (2025-2032) & (M USD)
Table 114. Middle East and Africa Long-acting and Short-acting Oral Contraceptives Consumption Forecast by Country (2025-2032) & (Units)
Table 115. Middle East and Africa Long-acting and Short-acting Oral Contraceptives Market Size Forecast by Country (2025-2032) & (M USD)
Table 116. Global Long-acting and Short-acting Oral Contraceptives Sales Forecast by Type (2025-2032) & (K MT)
Table 117. Global Long-acting and Short-acting Oral Contraceptives Market Size Forecast by Type (2025-2032) & (M USD)
Table 118. Global Long-acting and Short-acting Oral Contraceptives Price Forecast by Type (2025-2032) & (USD/MT)
Table 119. Global Long-acting and Short-acting Oral Contraceptives Sales (K MT) Forecast by Application (2025-2032)
Table 120. Global Long-acting and Short-acting Oral Contraceptives Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Long-acting and Short-acting Oral Contraceptives
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Long-acting and Short-acting Oral Contraceptives Market Size (M USD), 2019-2032
Figure 5. Global Long-acting and Short-acting Oral Contraceptives Market Size (M USD) (2019-2032)
Figure 6. Global Long-acting and Short-acting Oral Contraceptives Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Long-acting and Short-acting Oral Contraceptives Market Size by Country (M USD)
Figure 11. Long-acting and Short-acting Oral Contraceptives Sales Share by Manufacturers in 2023
Figure 12. Global Long-acting and Short-acting Oral Contraceptives Revenue Share by Manufacturers in 2023
Figure 13. Long-acting and Short-acting Oral Contraceptives Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Long-acting and Short-acting Oral Contraceptives Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Long-acting and Short-acting Oral Contraceptives Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Long-acting and Short-acting Oral Contraceptives Market Share by Type
Figure 18. Sales Market Share of Long-acting and Short-acting Oral Contraceptives by Type (2019-2024)
Figure 19. Sales Market Share of Long-acting and Short-acting Oral Contraceptives by Type in 2023
Figure 20. Market Size Share of Long-acting and Short-acting Oral Contraceptives by Type (2019-2024)
Figure 21. Market Size Market Share of Long-acting and Short-acting Oral Contraceptives by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Long-acting and Short-acting Oral Contraceptives Market Share by Application
Figure 24. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share by Application (2019-2024)
Figure 25. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share by Application in 2023
Figure 26. Global Long-acting and Short-acting Oral Contraceptives Market Share by Application (2019-2024)
Figure 27. Global Long-acting and Short-acting Oral Contraceptives Market Share by Application in 2023
Figure 28. Global Long-acting and Short-acting Oral Contraceptives Sales Growth Rate by Application (2019-2024)
Figure 29. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share by Region (2019-2024)
Figure 30. North America Long-acting and Short-acting Oral Contraceptives Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Long-acting and Short-acting Oral Contraceptives Sales Market Share by Country in 2023
Figure 32. U.S. Long-acting and Short-acting Oral Contraceptives Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Long-acting and Short-acting Oral Contraceptives Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Long-acting and Short-acting Oral Contraceptives Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Long-acting and Short-acting Oral Contraceptives Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Long-acting and Short-acting Oral Contraceptives Sales Market Share by Country in 2023
Figure 37. Germany Long-acting and Short-acting Oral Contraceptives Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Long-acting and Short-acting Oral Contraceptives Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Long-acting and Short-acting Oral Contraceptives Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Long-acting and Short-acting Oral Contraceptives Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Long-acting and Short-acting Oral Contraceptives Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Long-acting and Short-acting Oral Contraceptives Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Long-acting and Short-acting Oral Contraceptives Sales Market Share by Region in 2023
Figure 44. China Long-acting and Short-acting Oral Contraceptives Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Long-acting and Short-acting Oral Contraceptives Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Long-acting and Short-acting Oral Contraceptives Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Long-acting and Short-acting Oral Contraceptives Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Long-acting and Short-acting Oral Contraceptives Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Long-acting and Short-acting Oral Contraceptives Sales and Growth Rate (K MT)
Figure 50. South America Long-acting and Short-acting Oral Contraceptives Sales Market Share by Country in 2023
Figure 51. Brazil Long-acting and Short-acting Oral Contraceptives Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Long-acting and Short-acting Oral Contraceptives Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Long-acting and Short-acting Oral Contraceptives Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Long-acting and Short-acting Oral Contraceptives Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Long-acting and Short-acting Oral Contraceptives Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Long-acting and Short-acting Oral Contraceptives Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Long-acting and Short-acting Oral Contraceptives Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Long-acting and Short-acting Oral Contraceptives Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Long-acting and Short-acting Oral Contraceptives Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Long-acting and Short-acting Oral Contraceptives Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Long-acting and Short-acting Oral Contraceptives Production Market Share by Region (2019-2024)
Figure 62. North America Long-acting and Short-acting Oral Contraceptives Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Long-acting and Short-acting Oral Contraceptives Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Long-acting and Short-acting Oral Contraceptives Production (K MT) Growth Rate (2019-2024)
Figure 65. China Long-acting and Short-acting Oral Contraceptives Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Long-acting and Short-acting Oral Contraceptives Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Long-acting and Short-acting Oral Contraceptives Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Long-acting and Short-acting Oral Contraceptives Market Share Forecast by Type (2025-2032)
Figure 70. Global Long-acting and Short-acting Oral Contraceptives Sales Forecast by Application (2025-2032)
Figure 71. Global Long-acting and Short-acting Oral Contraceptives Market Share Forecast by Application (2025-2032)

DOWNLOAD SAMPLE

Download
Free Sample

Request
Customization

Check
Discount

REPORT PURCHASE OPTIONS

Single User Price : $3095

Multi User Price : $3762

Enterprise Price : $4333

---- OR ----

Frequently Asked Questions ?

Delivery Time

Upto 24 hrs - Working days
Upto 48 hrs max - Weekends and public holidays

User License

Single User License
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

Multi user License
A license granted to multiple users.

Site License
A license granted to a single business site/establishment.

Corporate License, Global License
A license granted to all employees within organisation access to the product.

Payment Options

Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer

Report Delivery

Email
Hard Copy

Our Key Features

Data Accuracy and Reliability
Data Security
Customized Research
Trustworthy
Competitive Offerings

Long-acting and Short-acting Oral Contraceptives Market, Global Outlook and Forecast 2025-2030